Stephen A Abraham, MD - Medicare Cardiovascular Disease (cardiology) in Boston, MA

Stephen A Abraham, MD is a medicare enrolled "Specialist" physician in Boston, Massachusetts. He went to Georgetown University School Of Medicine and graduated in 1984 and has 40 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). He is a member of the group practice Massachusetts General Physicians Organization Inc, North Suburban Cardiology Associates P.c. and his current practice location is 55 Fruit Street, Massachusetts General Hospital, Boston, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (617) 726-9292.

Stephen A Abraham is licensed to practice in Massachusetts (license number 75960) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1487743316.

Contact Information

Stephen A Abraham, MD
55 Fruit Street, Massachusetts General Hospital,
Boston, MA 02114
(617) 726-9292
Not Available



Physician's Profile

Full NameStephen A Abraham
GenderMale
SpecialityCardiovascular Disease (cardiology)
Experience40 Years
Location55 Fruit Street, Boston, Massachusetts
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Stephen A Abraham attended and graduated from Georgetown University School Of Medicine in 1984
  NPI Data:
  • NPI Number: 1487743316
  • Provider Enumeration Date: 10/11/2006
  • Last Update Date: 10/18/2011
  Medicare PECOS Information:
  • PECOS PAC ID: 1759351265
  • Enrollment ID: I20040730000252

Medical Identifiers

Medical identifiers for Stephen A Abraham such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1487743316NPI-NPPES
3093662MedicaidMA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RC0000XInternal Medicine - Cardiovascular Disease 75960 (Massachusetts)Secondary
207R00000XInternal Medicine 75960 (Massachusetts)Secondary
174400000XSpecialist 75960 (Massachusetts)Primary
207U00000XNuclear Medicine 75960 (Massachusetts)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Massachusetts General HospitalBoston, MAHospital
North Shore Medical Center -Salem, MAHospital
Brigham And Women's HospitalBoston, MAHospital
Winchester HospitalWinchester, MAHospital
Melrosewakefield HealthcareMelrose, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Massachusetts General Physicians Organization Inc24663658203085
North Suburban Cardiology Associates P.c.75178598796

News Archive

InHealth to further understand socioeconomic impact of medical devices and diagnostics

As the Institute for Health Technology Studies (InHealth) marks its five-year milestone, the research and educational nonprofit is taking stock of its contributions to objective evidence about the roles that medical technologies play in the economy, in the healthcare system, and in patients' lives.

FDA makes regulatory process for previously cleared 510(k) medical devices less challenging

The U.S. Food and Drug Administration today issued draft guidance that clarifies when changes or modifications to a previously cleared 510(k) device require a new premarket submission.

Maternal education can act as 'social vaccine' for childhood malaria infection, study finds

Every two minutes, a child will die from malaria in Africa. It is a preventable, treatable disease, that each year affects approximately 200 million people globally.

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with uncontrolled moderate-to-severe asthma. Dupilumab is an investigational therapy blocking IL-4 and IL-13, two cytokines required for the Th2 immune response.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Stephen A Abraham allows following entities to bill medicare on his behalf.
Entity NameMassachusetts General Physicians Organization Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801874573
PECOS PAC ID: 2466365820
Enrollment ID: O20031111000434

News Archive

InHealth to further understand socioeconomic impact of medical devices and diagnostics

As the Institute for Health Technology Studies (InHealth) marks its five-year milestone, the research and educational nonprofit is taking stock of its contributions to objective evidence about the roles that medical technologies play in the economy, in the healthcare system, and in patients' lives.

FDA makes regulatory process for previously cleared 510(k) medical devices less challenging

The U.S. Food and Drug Administration today issued draft guidance that clarifies when changes or modifications to a previously cleared 510(k) device require a new premarket submission.

Maternal education can act as 'social vaccine' for childhood malaria infection, study finds

Every two minutes, a child will die from malaria in Africa. It is a preventable, treatable disease, that each year affects approximately 200 million people globally.

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with uncontrolled moderate-to-severe asthma. Dupilumab is an investigational therapy blocking IL-4 and IL-13, two cytokines required for the Th2 immune response.

Read more Medical News

› Verified 4 days ago

Entity NameMiddlesex Cardiology Assoc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1508927922
PECOS PAC ID: 9436137387
Enrollment ID: O20040708000875

News Archive

InHealth to further understand socioeconomic impact of medical devices and diagnostics

As the Institute for Health Technology Studies (InHealth) marks its five-year milestone, the research and educational nonprofit is taking stock of its contributions to objective evidence about the roles that medical technologies play in the economy, in the healthcare system, and in patients' lives.

FDA makes regulatory process for previously cleared 510(k) medical devices less challenging

The U.S. Food and Drug Administration today issued draft guidance that clarifies when changes or modifications to a previously cleared 510(k) device require a new premarket submission.

Maternal education can act as 'social vaccine' for childhood malaria infection, study finds

Every two minutes, a child will die from malaria in Africa. It is a preventable, treatable disease, that each year affects approximately 200 million people globally.

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with uncontrolled moderate-to-severe asthma. Dupilumab is an investigational therapy blocking IL-4 and IL-13, two cytokines required for the Th2 immune response.

Read more Medical News

› Verified 4 days ago

Entity NameNorth Suburban Cardiology Associates P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1376515809
PECOS PAC ID: 7517859879
Enrollment ID: O20040823000780

News Archive

InHealth to further understand socioeconomic impact of medical devices and diagnostics

As the Institute for Health Technology Studies (InHealth) marks its five-year milestone, the research and educational nonprofit is taking stock of its contributions to objective evidence about the roles that medical technologies play in the economy, in the healthcare system, and in patients' lives.

FDA makes regulatory process for previously cleared 510(k) medical devices less challenging

The U.S. Food and Drug Administration today issued draft guidance that clarifies when changes or modifications to a previously cleared 510(k) device require a new premarket submission.

Maternal education can act as 'social vaccine' for childhood malaria infection, study finds

Every two minutes, a child will die from malaria in Africa. It is a preventable, treatable disease, that each year affects approximately 200 million people globally.

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with uncontrolled moderate-to-severe asthma. Dupilumab is an investigational therapy blocking IL-4 and IL-13, two cytokines required for the Th2 immune response.

Read more Medical News

› Verified 4 days ago

Entity NameThe General Hospital Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023049236
PECOS PAC ID: 6507803806
Enrollment ID: O20080313000351

News Archive

InHealth to further understand socioeconomic impact of medical devices and diagnostics

As the Institute for Health Technology Studies (InHealth) marks its five-year milestone, the research and educational nonprofit is taking stock of its contributions to objective evidence about the roles that medical technologies play in the economy, in the healthcare system, and in patients' lives.

FDA makes regulatory process for previously cleared 510(k) medical devices less challenging

The U.S. Food and Drug Administration today issued draft guidance that clarifies when changes or modifications to a previously cleared 510(k) device require a new premarket submission.

Maternal education can act as 'social vaccine' for childhood malaria infection, study finds

Every two minutes, a child will die from malaria in Africa. It is a preventable, treatable disease, that each year affects approximately 200 million people globally.

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with uncontrolled moderate-to-severe asthma. Dupilumab is an investigational therapy blocking IL-4 and IL-13, two cytokines required for the Th2 immune response.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Stephen A Abraham is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Stephen A Abraham, MD
55 Fruit Street, Massachusetts General Hospital,
Boston, MA 02114

Ph: (617) 726-9292
Stephen A Abraham, MD
55 Fruit Street, Massachusetts General Hospital,
Boston, MA 02114

Ph: (617) 726-9292

News Archive

InHealth to further understand socioeconomic impact of medical devices and diagnostics

As the Institute for Health Technology Studies (InHealth) marks its five-year milestone, the research and educational nonprofit is taking stock of its contributions to objective evidence about the roles that medical technologies play in the economy, in the healthcare system, and in patients' lives.

FDA makes regulatory process for previously cleared 510(k) medical devices less challenging

The U.S. Food and Drug Administration today issued draft guidance that clarifies when changes or modifications to a previously cleared 510(k) device require a new premarket submission.

Maternal education can act as 'social vaccine' for childhood malaria infection, study finds

Every two minutes, a child will die from malaria in Africa. It is a preventable, treatable disease, that each year affects approximately 200 million people globally.

Regeneron, Sanofi report positive results from dupilumab Phase 2b study in patients with asthma

Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with uncontrolled moderate-to-severe asthma. Dupilumab is an investigational therapy blocking IL-4 and IL-13, two cytokines required for the Th2 immune response.

Read more News

› Verified 4 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.